Beta Bionics, Inc. (BBNX) Equity Ratio (2023 - 2026)

Beta Bionics (BBNX) has 4 years of Equity Ratio data on file, last reported at 0.89 in Q1 2026.

• Quarterly Equity Ratio fell 4.0% year-over-year to 0.89 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.89 (down 4.0% YoY) and the FY2025 annual result came in at 0.87, up 153.36% from the prior year.
• Equity Ratio climbed to 0.89 in Q1 2026 per BBNX's latest filing, from 0.87 in the prior quarter.
• The five-year high for Equity Ratio was 0.93 in Q1 2025, with the low at 1.85 in Q4 2023.
• Average Equity Ratio over 4 years is 0.15, with a median of 0.89 recorded in 2026.
• Year-over-year, Equity Ratio surged 153.36% in 2025 and declined 4.0% in 2026.
• Beta Bionics' Equity Ratio stood at 1.85 in 2023, then rose by 11.17% to 1.64 in 2024, then surged by 153.36% to 0.87 in 2025, then grew by 1.85% to 0.89 in 2026.
• Business Quant data shows BBNX's Equity Ratio at 0.89 in Q1 2026, 0.87 in Q4 2025, and 0.89 in Q3 2025.